Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

ClinicalTrials.gov ID: NCT07169578

Public ClinicalTrials.gov record NCT07169578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).

Study identification

NCT ID
NCT07169578
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,101 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 17, 2025 (Actual)
Primary completion
Feb 16, 2028 (Estimated)
Completion
Feb 16, 2028 (Estimated)
Last update posted
Sep 25, 2026

2025 – 2028

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
34
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Banner Sun Health Research Institute Sun City Arizona 85351 —
Irvine Center for Clinical Research Irvine California 92614 —
Inglewood Clinicals Los Angeles California 90056 —
UCSF - Memory and Aging Center San Francisco California 94158 —
Syrentis Clinical Research Santa Ana California 92705 —
K2 Medical Research - The Villages Lady Lake Florida 32159 —
K2 Medical Research, LLC Maitland Florida 32751 —
Renstar Medical Research Ocala Florida 34470 —
Axiom Brain Health LLC Tampa Florida 33609 —
Charter Research - Lady Lake/The Villages The Villages Florida 32162 —
Alzheimer?s Research and Treatment Center Wellington Florida 33414 —
Conquest Research, LLC Winter Park Florida 32789 —
Alzheimer's Research and Treatment Center - Columbus Columbus Georgia 31904 —
Accel Research Sites-NeuroStudies Decatur Georgia 30030 —
Hawaii Pacific Neuroscience Honolulu Hawaii 96817 —
RE:Cognition (Chicago) Chicago Illinois 60611 —
Tandem Clinical Research, LLC Marrero Louisiana 70072 —
Brigham and Womens Hospital Boston Massachusetts 02115 —
Boston Center for Memory Newton Massachusetts 02459 —
Washington University School of Medicine St Louis Missouri 63110 —
The Cognitive and Research Center of New Jersey Ridgewood New Jersey 07450 —
Basil Clinical Laurelton New York 11413-2016 —
Weill Cornell Medical College New York New York 10021 —
Adams Clinical Harlem New York New York 10029 —
Adams Clinical Bronx The Bronx New York 10461 —
Triad Clinical Trials Greensboro North Carolina 27410 —
Ohio State University Columbus Ohio 43221 —
Butler Hospital Providence Rhode Island 02906 —
Genesis Neuroscience Clinic Knoxville Tennessee 37909 —
K2 Medical Research - Nashville Nashville Tennessee 37204 —
Kerwin Research Center, LLC Dallas Texas 75231 —
South Texas Research Institute - Edinburg Edinburg Texas 78539 —
Re:Cognition Health - Houston Houston Texas 77030 —
National Clinical Research Inc.-Richmond Richmond Virginia 23294 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 107 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07169578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07169578 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →